(r)-oxybutynin citrate material, production process and solid crystalline form thereof, and pharmaceutical composition comprising the solid crystalline form

TW202639505APending Publication Date: 2026-10-01APNIMED INC (DELAWARE)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115104747
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-01-13
Filing Date
2021-05-05
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001079311_001
    Figure TWG2TA001079311_001
  • Figure TWG2TA001079311_002
    Figure TWG2TA001079311_002
  • Figure TWG2TA001079311_003
    Figure TWG2TA001079311_003
Patent Text Reader

Abstract

Polymorphic forms of (R)-oxybutynin HCl, including three crystalline forms, are prepared and characterized. Uses of the various polymorphic forms of (R)-oxybutynin HCl for Obstructive Sleep Apnea (OSA) treatment are also disclosed.
Need to check novelty before this filing date? Find Prior Art